Recent Articles from GlobeNewswire

Milestone reflects LexisNexis’s leadership in delivering secure, compliant, cloud-based legal technology to U.S. government agencies

Spun out from Splash Clinical, SplashBIO™ brings biomarker pre-screening to the front of the clinical trial — built to reduce screen failures and accelerate enrollment. The newly independent company will be at the Alzheimer’s Association International Conference (AAIC) 2026.

SCOTTSDALE, Ariz., July 07, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced that the U.S. Department of Veterans Affairs (VA) has initiated an administrative modification to transition the Company’s Federal Supply Schedule (FSS) contract to the VA’s updated Evergreen contract structure. Upon execution of the administrative modification, the contract structure will transition from a five-year base period with one five-year option period to a five-year base period with three five-year option periods. Subject to the Government’s future exercise of those option periods in accordance with the contract, the updated structure provides the potential for continued availability of XWRAP® through the VA Federal Supply Schedule for up to 20 years.

MARIETTA, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for the second quarter ended June 30, 2026, on Thursday, July 30, 2026, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at investors.donegalgroup.com, concurrently with its earnings press release.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (NASDAQ: NNOX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

New full-size pillow with a lower, kid-friendly loft is GOTS-certified as a finished product — cover and fill

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. (“Embecta” or “the Company”) (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Microsoft Corporation (“Microsoft” or “the Company”) (NASDAQ: MSFT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or “the Company”) (NASDAQ: BRCB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Frank Harmon Black and Southeast Investments, N.C., Inc. v. Securities and Exchange Commission and Financial Industry Regulatory Authority, Inc.

Vasco Electronics’ browser-based platform takes top honors in the Secondary Education category for driving equitable parent and student engagement

Latest Milestone Builds on Cisco 360 Preferred Partner Status Across All Six Portfolios and Americas Networking Partner of the Year Recognition

New offerings across performance management, leave of absence, and ARIES™ agents expand Mitratech's Workforce Compliance Platform

Industry veteran joins team to lead FASHION by Informa’s key marketplaces, including MAGIC, PROJECT, and OFFPRICE.

National effort positions HBCUs to lead in building career-connected learning pathways through an institution-centered approach to work-integrated learning

USPTO grant validates the governed, human-in-the-loop AI approach Patra has built since 2022, the same principles that underpin its agentic automation platform.

Collaboration connects European development expertise with U.S. manufacturing to give medtech innovators a seamless path from concept to commercialization for safety-critical medical devices.

The partnership includes a committed pilot project and commercial deployments with priority access to future capacity for GridMarket’s pipeline of C&I, data center and hyperscaler customers

Shareholder argues equity-financed M&A will strengthen CBIZ’s competitive position, reduce balance sheet risk, and deliver attractive returns; releases proposal at cbizflywheel.com

In a challenge brought by The Gillette Company, BBB National Programs’ National Advertising Division found that Mammoth Brands, Inc. (Harry’s) provided a reasonable basis for certain claims for its Harry’s Plus razors

BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration with Kite, a Gilead Company and global leader in cell therapy, to deploy BBG Advanced Therapies’ Mobile Leukapheresis Center (MLC) across Texas—marking an important milestone in how patients can access Kite’s CAR T-cell therapies which are individualized cancer treatments made from a patient’s own cells.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ADMA Biologics, Inc. (“ADMA” or “the Company”) (NASDAQ: ADMA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Veteran strategist behind campaigns for Doctors Without Borders, the ACLU, and Greenpeace offers a four-part persuasion framework in a new book published by Palmetto Publishing.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zillow Group, Inc. (“Zillow” or “the Company”) (NASDAQ: Z) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Via Transportation, Inc. (“Via” or “the Company”) (NYSE: VIA) for violations of the federal securities laws.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against BitGo Holdings, Inc. (“BitGo” or “the Company”) (NYSE: BTGO) for violations of the federal securities laws.

After two years building talent infrastructure for the government and public sector, Neuroscale AI brings its most powerful product to the commercial market.

New York, NY, July 07, 2026 (GLOBE NEWSWIRE) -- STV today announced that Justin Ramirez, Esq., has joined the firm as vice president of mergers and acquisitions (M&A). He will lead the identification and execution of strategic acquisitions with long-term enterprise value as STV accelerates growth in high-priority markets and services.

Boutique multifamily community sits at the center of a $3.2 billion medical development boom

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Roblox Corporation (“Roblox” or “the Company”) (NYSE: RBLX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GRAIL, Inc. (“Grail” or “the Company”) (NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Peabody Energy Corporation (“Peabody Energy” or the “Company”) (NYSE: BTU) between October 14, 2024 and May 4, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the Class A ordinary shares of Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) between November 7, 2024 and April 21, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Badger Meter, Inc. (“Badger Meter” or the “Company”) (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Verra Mobility Corporation (“Verra” or the “Company”) (NASDAQ: VRRM) between February 24, 2026 and May 26, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased PicS N.V. (“PicS” or the “Company”) (NASDAQ: PICS) Class A common stock in and/or traceable to PicS’ January 30, 2026 initial public offering (“IPO”).

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired Class A (NASDAQ: ZG) or Class C (NASDAQ: Z) common stock of Zillow Group, Inc. (“Zillow” or the “Company”) between February 11, 2025 and May 7, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Calix, Inc. (“Calix” or the “Company”) (NYSE: CALX) between January 28, 2026 and April 21, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or the “Company”) (NASDAQ: BRCB) Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s September 2025 initial public offering; and/or (b) Black Rock Coffee securities between September 12, 2025 and May 12, 2026, inclusive (the “Class Period”).

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of ZoomInfo Technologies Inc. (“ZoomInfo” or the “Company”) (NASDAQ: GTM) between November 3, 2025 and May 11, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of GRAIL, Inc. (“GRAIL” or the “Company”) (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who sold the common stock of ChampionX Corporation (“ChampionX” or the “Company”) (formerly NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) BitGo Holdings, Inc. (“BitGo” or the “Company”) (NYSE: BTGO) Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s January 22, 2026 initial public offering; and/or (b) BitGo securities between January 22, 2025 and May 13, 2026, both dates inclusive (the “Class Period”).

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) between April 28, 2023 and May 11, 2026, inclusive.

MIAMI, July 07, 2026 (GLOBE NEWSWIRE) -- Rhino Bitcoin Inc. (OTC: RHNO) today announced very strong user growth, with new KYC-verified users more than tripling since the start of Q2. The surge signals accelerating mainstream adoption and positions Rhino to capture rising institutional, corporate, and retail demand for Bitcoin.

Chicago's iconic pizza brand expands its Minnesota footprint with a new restaurant at one of the world's premier retail and entertainment destinations

Gemini has launched 0% commission stock trading, marking another major milestone in its march to become an all-in-one super app

WASHINGTON, July 07, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) released an Ibogaine Investigator’s Brochure (IB), a comprehensive scientific and regulatory resource summarizing the current preclinical, safety, dosing, and observational data on ibogaine. It is the first time a technical document of this scope has been made freely and publicly available.

MCLEAN, Va., July 07, 2026 (GLOBE NEWSWIRE) -- By Light Professional IT Services LLC (By Light) today announced it has been awarded a five-year task order under the ENCORE III Large Business vehicle to support the U.S. Army’s Comprehensive Modernization (COMPMOD) program with a lifecycle value of $209M. The award marks a significant new initiative supporting the Product Manager Global Enterprise Network Modernization – Americas (PdM GENMA) in delivering a cohesive, secure, and modernized network infrastructure across Army installations throughout the contiguous United States (CONUS).

Embedded event execution capabilities for SAP Engagement Cloud and SAP Sales Cloud V2

CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided a business update on its second quarter and first-half revenue performance and share repurchase activity.

COLUMBIA, Mo., July 07, 2026 (GLOBE NEWSWIRE) -- StorageMart continues to grow its Third Party Management portfolio with the addition of two new managed facilities in Crystal Lake, Illinois, and Indianapolis, Indiana. Together, these properties add more than 134,000 net rentable square feet and expand StorageMart's presence in two key Midwest markets.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- NordVPN, a global provider of cybersecurity solutions, is making its subscriptions available to eligible cardholders as part of their existing card benefits. This enables select banks and issuers in selected countries to add NordVPN Basic and NordVPN Standard to their Mastercard card programs, strengthening their benefits portfolio with digital security services.

REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has started a phased review of data on daraxonrasib, the company's investigational RAS(ON) multi-selective inhibitor. A phased review aims to accelerate the assessment of a medicine by evaluating the data in phases as they become available, ahead of the submission of a full marketing authorization application. Daraxonrasib was designated by the EMA as an orphan medicinal product for the treatment of pancreatic cancer and has been recognized as a high priority under EMA’s Cancer Medicines Pathfinder project based on its potential to address a high unmet medical need.

Harrison Brown and Erica Graves bring extensive experience in high-stakes litigation, advertising and privacy matters

Initial Deployment Brings Omni One Systems to Sirica's First Bay Area Treatment Center

15% revenue growth and 80 new clients in the first half put the company ahead of its previous 12 years

eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease | Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220 panel and as a single-plex assay through the Technology Access Program | Data to be featured in Alamar’s workshop at AAIC 2026

– Partnership gives freight brokers additional visibility into carrier risk through Highway’s Carrier Identity® platform –

JEDDAH, Kingdom of Saudi Arabia, July 07, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world’s first protocol of its kind, using an algorithm to accurately estimate the expected stem cell yield from each donor. The protocol enabled stem cell collection to be completed in the first session for 100% of male donors and 94.9% of all donors, while eliminating the need for third and fourth collection sessions altogether.

PHILADELPHIA, July 07, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against ChampionX Corporation (NASDAQ: CHX) (“ChampionX” or the “Company”) on behalf of investors who sold ChampionX common stock during the period from February 29, 2024 through April 1, 2024 (the “Class Period”).